ALLMedicine™ Retinal Vein Occlusion Center
Research & Reviews 989 results
https://clinicaltrials.gov/ct2/show/NCT04740905
May 18th, 2022 - This is a Phase III, multicenter, randomized, double-masked, active comparator-controlled, parallel-group study evaluating the efficacy, safety, and pharmacokinetics of faricimab administered by intravitreal (IVT) injection at 4-week intervals unt...
https://doi.org/10.1136/bjophthalmol-2022-321225
The British Journal of Ophthalmology; Frederiksen KH, Stokholm L et. al.
May 11th, 2022 - Associations between retinal vein occlusion (RVO) and subsequent cardiovascular disease (CVD) or mortality have not been evaluated in a recent cohort, after novel therapeutic options have increased referrals for treatment of the condition. We aime...
https://doi.org/10.1007/s10792-022-02344-z 10.7189/jogh.09.010427 10.1016/j.ophtha.2009.07.017 10.1159/000455278 10.1016/j.ophtha.2010.01.060 10.1517/14712598.2015.1086744 10.1159/000502041 10.1159/000497492 10.1038/s41433-021-01702-y 10.1371/journal.pone.0234739 10.1016/j.ophtha.2011.02.038 10.1016/j.ophtha.2011.02.022 10.1016/j.ophtha.2015.09.035 10.1001/jamaophthalmol.2018.6111 10.1007/s00417-017-3613-1 10.1016/j.sjopt.2017.09.009 10.1186/s40942-016-0054-7 10.1080/17434440.2020.1755256 10.1097/IAE.0000000000001070 10.1097/IAE.0000000000001579 10.1167/tvst.10.3.31 10.1007/s13167-021-00233-6 10.1016/j.oret.2021.02.008 10.1089/jop.2020.0130 10.1089/jop.2019.0011 10.4161/cbt.9.9.11691 10.1159/000440848 10.1016/j.ajo.2013.05.039 10.1159/000462976 10.1016/j.ophtha.2019.07.018 10.1001/jamaophthalmol.2019.3305 10.1097/IAE.0000000000001566
International Ophthalmology; Chatziralli I, Kazantzis D et. al.
May 11th, 2022 - To investigate potential laboratory and imaging biomarkers as treatment response predictors to intravitreal anti-vascular endothelial growth factor (anti-VEGF) agents in patients with retinal vein occlusion (RVO). Participants in this prospective ...
https://doi.org/10.1177/11206721221099487
European Journal of Ophthalmology; Mejía ME, Ríos HA et. al.
May 6th, 2022 - Evaluate optical coherence tomography angiography (OCT-A) features in retinal vein occlusions (RVO) associated with visual outcomes after anti-VEGF. Analytical observational study performed in eyes with macular edema secondary to RVO treated with ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9066999
Eye (London, England); Bhandari S, Nguyen V et. al.
May 5th, 2022 - To identify whether the outcomes of neovascular age-related macular degeneration (nAMD), diabetic macular oedema (DMO) and retinal vein occlusion (RVO) in routine clinical practice have changed over time. We analysed 12-month outcomes in treatment...
Drugs 6 results see all →
Clinicaltrials.gov 80 results
https://clinicaltrials.gov/ct2/show/NCT04740905
May 18th, 2022 - This is a Phase III, multicenter, randomized, double-masked, active comparator-controlled, parallel-group study evaluating the efficacy, safety, and pharmacokinetics of faricimab administered by intravitreal (IVT) injection at 4-week intervals unt...
https://clinicaltrials.gov/ct2/show/NCT05345808
Apr 26th, 2022 - Retinal vein occlusion (RVO) is considered the second vascular disorder of the retina after diabetic retinopathy. Patients with RVO are at risk of the development of macular edema. Different treatment modalities for macular edema include LASER the...
https://clinicaltrials.gov/ct2/show/NCT01746615
Apr 7th, 2022 - Assessment of retinal vessel calibers combined with bidirectional Fourier domain optical coherence tomography (FDOCT) for measurement of retinal blood velocities is a new and sophisticated method for assessing retinal blood flow in humans. The val...
https://clinicaltrials.gov/ct2/show/NCT03061526
Mar 23rd, 2022 - Several studies tried to classify retinal ischemia due to retinal artery or vein occlusion into different grades. In some cases prognosis is dependent on grade of severity, especially in cases of retinal vein occlusion. State of the art to Diagnos...
https://clinicaltrials.gov/ct2/show/NCT05003258
Mar 14th, 2022 - Aim of the research is To evaluate functional and anatomical outcomes of ozurdex injection in patients with RVO related macular edema. And evaluation of the safety of ozurdex injections regarding intraocular pressure increase, cataract development...
News 85 results
https://www.medscape.com/viewarticle/972265
Apr 18th, 2022 - (Reuters) - Patients with COVID-19 may have an increased risk of rare vision-threatening blood clots in the eye for months afterward, new findings suggest. Because SARS-CoV-2 infections increase the risk of blood vessel obstructions at other sites...
https://www.medpagetoday.com/ophthalmology/generalophthalmology/98212
Apr 14th, 2022 - COVID-19 infection may be boosting the numbers of a rare ocular condition in which vision is threatened when veins in the retina are blocked, eye specialists in Southern California report. Risk of retinal vein occlusion was higher in the 6 months ...
https://www.medscape.com/viewarticle/959087
Sep 20th, 2021 - The US Food and Drug Administration (FDA) has approved the first biosimilar for ophthalmology, Byooviz (ranibizumab-nuna), which will be indicated for neovascular (wet) age-related macular degeneration (nAMD), macular edema following retinal vein ...
https://www.medscape.com/viewarticle/950709
May 6th, 2021 - Many people with neovascular age-related macular degeneration (nAMD) lost less vision than expected during treatment delays imposed by COVID-19, researchers say. The finding suggests that physicians may be overtreating these patients, said James T...
https://www.onclive.com/view/novel-agents-revolutionize-melanoma-treatment
Dec 5th, 2020 - The mechanism of action of vemurafenib (Zelboraf) in inhibiting BRAF activity. Until recently, the cornerstone of therapy for metastatic melanoma had been chemotherapy with dacarbazine (DTIC) and immunotherapy with high-dose interleukin-2 (HD IL-...
